UNSPSC 51351625: Estradiol monopalmitate

This classification denotes an estrogen C34H54O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Q5Y448XT0, chemically known as estra-1,3,5(10)-triene-3,17-.beta.-diol 17-palmitate, but more generally known as estradiol monopalmitate, which bears US NIH Compound Identifier 111095. Most nations, for tariff and trade purposes, schedule estradiol monopalmitate under HS 29372300 and SITC 54153. As of Q4 2014, ESTRADIOL MONOPALMITATE remains US FDA's Preferred Term for this commodity.

Estradiol monopalmitate bears US NLM identifiers UMLS ID C2700019 and NCI Concept Code C76110. SMILES: CCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4C3CCC(C4)O)C.

UNSPSC 51351625 Estradiol monopalmitate is a Commodity code representing a specific pharmaceutical active ingredient used in hormone replacement and therapeutic formulations procured by state and local health agencies. State and local governments purchase estradiol monopalmitate primarily through health departments, state Medicaid programs, and public health clinics as a component of pharmaceutical products or as bulk active pharmaceutical ingredient for compounding within regulated state facilities. The procuring bodies are typically state health departments and Medicaid agencies that manage prescription drug formularies and public health clinic supply chains.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitations, the geographic spread and current procurement activity cannot be characterized from available records.